Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06503965

Tunisian Registry of Trans Catheter Aortic Valve Implantation

Design and Rationale of the National Multicenter Tunisian Registry of Trans Catheter Aortic Valve Implantation Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Les Laboratoires des Médicaments Stériles · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Transcatheter aortic valve implantation (TAVI) has emerged as a transformative therapy for patients with severe aortic stenosis, particularly those designated high-risk or inoperable for traditional surgical valve replacement. Despite its increasing adoption worldwide, there re-mains a paucity of data regarding TAVI outcomes in Tunisian patients. In response to this gap in knowledge, the investigators propose the establishment of the Tunisian TAVI Registry, a multicenter initiative aimed at comprehensively documenting the clinical characteristics, procedural de-tails, and short- and long-term outcomes of TAVI procedures across Tunisia. The TAVI.TN registry will enroll consecutive patients undergoing TAVI procedures at participating centers across Tunisia, between 2013 and 2024 with a retrospective arm and a prospective arm. The TAVI-TN Registry represents a significant step towards enhancing our understanding of TAVI outcomes in the Tunisian population. By systematically capturing real-world data, this initiative aims to inform clinical decision-making, improve patient care, and contribute to the advancement of TAVI practices in Tunisia and beyond.

Conditions

Timeline

Start date
2023-09-23
Primary completion
2025-06-23
Completion
2025-12-31
First posted
2024-07-16
Last updated
2024-11-29

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT06503965. Inclusion in this directory is not an endorsement.